Modern total shoulder arthroplasty seeks to produce a construct that reproduces the kinematics and stability of the native glenohumeral joint. The latest 4th generation implants are modular, adaptable, and capable of use as either anatomic or reverse shoulder arthroplasty components. During surgery, these implants are “universal”; post-operatively, they are “convertible”. Recent work has demonstrated that reverse shoulder arthroplasty components may indeed be the emerging standard of care for most (if not all) shoulder arthroplasty indications. As this new frontier develops, the use of a
Introduction. Total Elbow Arthroplasty (TEA) is recognized as an effective treatment solution for patients with rheumatoid arthritis or for traumatic conditions. Current total elbow devices can be divided into linked or unlinked design. The first design usually presents a linking element (i.e. an axle) to link together the ulnar and humeral components to stabilize the joint; the second one does not present any linkage and the stability is provided by both intrinsic design constraints and the soft tissues.
The results of revision TSA do not historically match the results of primary TSA. This is especially true if the diagnosis is a soft tissue related problem that leads to the revision. When a revision TSA is considered in this setting, instability is the major problem to overcome and a reverse TSA is most often needed. In the past this would require that the glenoid and humeral components be removed. Some manufacturers have produced shoulder prosthetic systems that can be converted to a reverse TSA without removing the humeral stem making the revision surgery potentially easier for both the patient and the surgeon. The data bank from two academic shoulder services were utilised to compare outcomes of revision TSA with and without removing the humeral stem at the time of revision surgery. Sixty-seven patients were identified in which 22 did not have the stem removed and 45 required the stem to be revised. The pre-operative and post-operative data for 1 and 2 years were available. Codman's scores, range of motion, estimated blood loss, time in the operating room, complications and cost of the implants were evaluated. The average blood loss was 280 cc vs. 500 cc, 145 minutes vs. 211 minutes, constant scores were 32 pre-op and 75 post-op vs. 32 pre-op and 70 post-op, complications 0 vs. 9 and the cost of the implants were 23% more in the stem removal group. The results of revision TSA do not match the results of primary arthroplasty. The results of not having to remove the humeral stem when doing a revision arthroplasty vs. using a system that has to remove both components has certain advantages. The overall outcome score are similar, however, the complication rate, blood loss, time in the operating room and cost of the implants are significantly less.
Humeral component failure in total shoulder arthroplasty has been rare with contemporary design systems. Are stemless implant designs superior to contemporary short-stem humeral component technologies? This presentation will provide information to address this question. Stemless technology became available in Europe and other parts of the world in 2004 and 2005 compared to only recently in the United States of America. Short-stem designs have developed with third generation implant systems. Advantages of short-stem implant designs include the following: the humeral canal facilitates proper head component position; modularity between the stem and head allows for modifications of version, inclination and offset to match the native anatomy and these designs are
Experience has demonstrated in the hip and knee, related to total joint replacement arthroplasty, polymethyl methacrylate cement fixation can provide problems in terms of loosening, fragmentation, particulate wear and ultimate failure. These same problems have been recognised in total shoulder arthroplasty related to cement fixation of the glenoid. While cement fixation of the humeral component has proven much less problematic, there has been a swelling towards avoidance of using cement to secure the humeral component for fear of difficulty if revision is required. Surprisingly, with the high incidence of lucent lines, bone resorption and frank loosening, representing the most common source of failure in total shoulder arthroplasty, cementless fixation of the glenoid has not been, until now, embraced. The advent of reverse total shoulder arthroplasty has demonstrated the ability for secure cementless fixation to provide long-lasting secure implant retention in implants which have inherently higher shear and stress forces passing through the implant/bone interface. In anatomic total shoulder arthroplasty a woven tantalum anchor (Trabecular Metal) has proven to demonstrate secure cementless fixation as well. This presentation will discuss the use of trabecular metal anchored glenoid implants with and without additional screw fixation for anatomic and
Arthroplasty implant modularity enables the surgeon to adapt the joint replacement construct to the patient's requirements, and often facilitates revision procedures. Total shoulder arthroplasty humeral modularity exists for many implant systems. Glenoid modularity with
Revision shoulder arthroplasty for failure secondary to soft tissue problems has improved with the availability of the reverse total shoulder system. The initial concept of a platform (convertible) stem was introduced in 2006. Removal of a well-fixed humeral stem can be a significant challenge and may require the surgeon to use osteotomy windows to successfully remove the implant. The increased time in the operating room, potential for complications and the cost of replacing the humeral component are all factors that make platform stem use a important consideration. The first report on total shoulder arthroplasty revision utilizing the platform stem concept confirmed improvements in patient morbidity and decreased costs. However, the overall functional improvement did not reveal a statistically significant improvement in pain relief or range of motion compared to those patients that had the humeral stem revised. Almost all major companies have adopted this concept of a
The modern humeral head resurfacing was developed by Stephen Copeland, M.D. and introduced in 1986 as an alternative to stemmed humeral implants. At the time, first and second generation monoblock and modular stems with non-offset humeral heads posed many challenges to the surgeon to recreate the pre-morbid humeral head anatomy during anatomic TSA. The consequences of non-anatomic humeral head replacement were poor range of motion, increased native glenoid or glenoid component wear and premature rotator cuff failure. Additionally, the early generation humeral stems were very difficult to extract when revision was needed. The original stemless devices were cup resurfacing implants that were designed based on the early hip experience. The Copeland resurfacing device offered the ability to better match native humeral head anatomy and was considered less invasive and easier to revise. Glenoid exposure required more extensive dissection but TSA could be successfully completed. Clinical results for motion, function and outcome scores are similar to stemmed implants. The survivorship of the implants is also on par with other available implants and loosening has not been an issue. Stress shielding is not reported. Multiple manufacturers offered similar products all designed to try to predictably recreate the pre-morbid anatomy and to make insertion easier. Critical review of resurfacing arthroplasty radiographs has raised concern about the challenges of placing the implant with proper sizing and position. Most surgeons have implanted resurfacing implants as hemiarthroplasties. The development of anatomic TSA implants has allowed surgeons to better recreate the normal pre-morbid anatomy of the humerus. Newer stem designs are